Invest in intelligence that delivers

Spherix Market Expertise

Our team of experts and physician
community give you a competitive edge.

See the market from the prescribers’ point of view.

Our physician community includes direct relationships with our curated physician network and leading KOLs, who keep us closely connected with the specific challenges of specialty markets.

Vetted Practicing Physicians

Key Opinion Leaders

Professional Organizations

3,300+ members in the Spherix US Physician Community

Our therapeutic experts are always just a click or call away...

  • Plugged into the ever-evolving landscape
  • Ready to provide an unbiased view of the landscape
  • Insightfully answer real-time questions
  • Highlight opportunities 
  • Identify disruptors

Dermatology

Expertise

5

dedicated team members

8

years of
continuous tracking

36

studies published annually

Indications

  • Alopecia Areata (AA)
  • Atopic Dermatitis (AD)
  • Hidradenitis Suppurativa (HS)
  • Plaque Psoriasis (PsO)
  • Prurigo Nodularis (PN)
  • Vitiligo

Team Lead

Gianna Melendez
Franchise Head, Dermatology

Gianna has been with Spherix since 2017. Prior to Spherix, Gianna received her master’s degree in experimental psychology from Saint Joseph’s University. She previously worked at the University of Pennsylvania conducting clinical trials focusing on women’s health.

Gastroenterology

Expertise

4

dedicated team members

8

years of
continuous tracking

26

studies published annually

Indications

  • Celiac Disease
  • Clostridioides Difficile (Cdiff)
  • Crohn’s Disease (CD)
  • Eosinophilic Esophagitis (EoE)
  • Irritable Bowel Syndrome (IBS)
  • Metabolic dysfunction-associated steatotic liver disease/ metabolic dysfunction-associated steatohepatitis (MASLD/MASH) (previously NAFLD/NASH)
  • Primary Biliary Cholangitis (PBC)
  • Ulcerative Colitis (UC)

Team Lead

Jim Hickey
Franchise Head, Gastroenterology

Jim has 20+ years’ experience building and leading research teams, pioneering innovative research techniques, and providing insight solutions to pharmaceutical brands. Prior to Spherix, he led the research team at Verilogue from early startup through its acquisition by Publicis Health. Jim has extensive experience across a wide range of therapeutic categories and a particular interest in gastroenterology and inflammatory disease.

Rheumatology

Expertise

5

dedicated team members

9

years of
continuous tracking

28

studies published annually

Indications

  • ANCA-associated Vasculitis
  • Ankylosing Spondylitis And Non-radiographic Axial Spondylitis (AS and nr-axSpA)
  • Cutaneous Lupus Erythematosus (CLE)
  • Dermatomyositis (DM)
  • Giant Cell Arteritis (GCA)
  • Lupus Nephritis (LN)
  • Polymyalgia Rheumatica (PMR)
  • Psoriatic Arthritis (PsA)
  • Rheumatoid Arthritis (RA)
  • Sjögren’s Syndrome (SjS)
  • Systemic Sclerosis (SSc)
  • Systemic Lupus Erythematosus (SLE)

Team Lead

Maxine Yarnall
Franchise Head, Rheumatology
Maxine has been with Spherix since 2020 and has 13 years’ experience in pharmaceutical and healthcare marketing research. She has extensive experience in custom and syndicated market research, both domestic and globally, across a wide range of methodologies and indications.

Nephrology

Expertise

6

dedicated team members

9

years of
continuous tracking

40

studies published annually

Indications

  • Alport Syndrome
  • Bone and Mineral Metabolism
  • Chronic Kidney Disease (CKD)
  • CKD-associated Pruritus (CKD-aP)
  • Complement 3 Glomerulopathy (C3G)
  • Diabetic Kidney Disease (DKD)
  • Dialysis
  • Focal Segmental Glomerulosclerosis (FSGS)
  • Glomerular Disease and Nephritis
  • Hyperkalemia
  • Hyperphosphatemia
  • IgA Nephropathy (IgAN)
  • Lupus Nephritis (LN)
  • Membranous Nephropathy (MN)
  • Polycystic Kidney Disease (ADPKD)
  • Renal Anemia

Team Lead

Meghan Weiss 
Franchise Head, Nephrology
Meghan joined Spherix in 2020. Prior to Spherix, she managed custom market research projects across a broad range of industries and developed expertise with complex research methodologies. She holds an MBA with a focus in Health Sector Management from Pennsylvania State University.

Neurology

Expertise

3

dedicated team members

9

years of
continuous tracking

34

studies published annually

Indications

  • Alzheimer’s Disease (AD)
  • Amylotrophic Lateral Sclerosis (ALS)
  • Chronic inflammatory demyelinating polyneuropathy (CIDP)
  • Epilepsy
  • Generalized Myasthenia Gravis (gMG)
  • Huntington’s Disease (HD)
  • Migraine
  • Multiple Sclerosis (MS)
  • Parkinson’s Disease (PD)

Team Lead

Blaine Cloud
Franchise Head, Neurology
Blaine is a neuroscientist with significant experience in clinical research, commercial development, in-line marketing and biopharmaceutical insight research and consulting. He has over 50 scientific publications and presentations, as well as experience on the advertising side of the industry.

Ophthalmology

Expertise

3

dedicated team members

2

years of
continuous tracking

18

studies published annually

Indications

  • Diabetic Macular Edema (DME)
  • Diabetic Retinopathy (DR)
  • Dry Age-related Macular Degeneration (AMD)
  • Geographic Atrophy (GA)
  • Gene Therapies In Retinal Disorders
  • Neovascular Age-related Macular Degeneration (nAMD)

Team Lead

Blaine Cloud
Franchise Head,  Ophthalmology

Blaine is a neuroscientist with significant experience in clinical research, commercial development, in-line marketing and biopharmaceutical insight research and consulting. He has over 50 scientific publications and presentations, as well as experience on the advertising side of the industry.

Hematology

NEW in 2024!

3

dedicated team members

9

years of
continuous tracking

34

studies published annually

Indications

  • Autoimmune Hemolytic Anemia (AIHA)
  • Cold Agglutinin Disease (CAD)
  • Hemophilia
  • Immune thrombocytopenic purpura (ITP)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Sickle Cell Disease (SCD)
  • Thalassemia
  • Thrombotic thrombocytopenic purpura (TTP)

Team Lead

Tucker Hurtado
Launch Franchise Head, Hematology
Blaine is a neuroscientist with significant experience in clinical research, commercial development, in-line marketing and biopharmaceutical insight research and consulting. He has over 50 scientific publications and presentations, as well as experience on the advertising side of the industry.
Sign up for alerts, market insights and exclusive content in your inbox.

Spherix is excited to announce our expansion into an additional, rapidly evolving specialty market:

HEMATOLOGY

Throughout 2024, we will be publishing over
10 groundbreaking studies covering a wide range of indications within classical hematology.